Enliven Therapeutics Inc. (ELVN)
19.80
-0.23 (-1.15%)
At close: Apr 04, 2025, 9:44 AM
13F Institute Ownership
Total Institutes of 112 in Enliven Therapeutics expanded their positions with an increase of 10 investors compared to the previous quarter. An additional 1.94M shares, as total invested capital declined by $101.44M with ownership percentage increasing from 98.80% to 102.81%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.273
0.27
Call Flow 1,100
79%
Put Flow 300
21%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 16.49% | 7.96M | +0.00% | 179.09M | 3.70% |
| FMR LLC | 13.46% | 6.5M | +3.17% | 146.16M | < 0.01% |
| Commodore Capital LP | 8.71% | 4.21M | +2.56% | 94.61M | 6.93% |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.